Governments worldwide are undertaking various initiatives to enhance foot and mouth disease (FMD) vaccination programs, recognizing the significant impact of FMD on livestock health, agricultural productivity, and economic stability.
These initiatives focus on improving vaccine accessibility, ensuring comprehensive immunization coverage, and fostering international collaboration to control and eventually eradicate FMD. For instance, in August 2022, the government of Queensland approved USD 20 million to bolster defense strategies against foot and mouth disease in the region.
Many governments provide financial support and subsidies to reduce the cost burden of FMD vaccines for farmers. By subsidizing vaccine costs, governments make vaccination more affordable and encourage widespread adoption among livestock owners. For example, in India, the government launched the National Animal Disease Control Program (NADCP), which aims to vaccinate 100% of the country's cattle, sheep, pigs, buffalo, and goats against FMD.
Organized vaccination campaigns are a crucial part of government initiatives. These campaigns are often conducted in collaboration with veterinary services and agricultural departments to ensure systematic and timely vaccination of livestock. For instance, in April 2024, the government of Brazil conducted a nationwide foot and mouth disease vaccination campaign with the aim of combating potential FMD outbreaks. The government plans to make the country FMD-free by 2026.
Raising awareness about the importance of FMD vaccination is another critical focus area. Governments run educational programs and workshops for farmers, veterinarians, and other stakeholders to inform them about the benefits of vaccination, proper vaccination techniques, and the risks associated with FMD outbreaks.
Effective surveillance systems are essential for tracking FMD outbreaks and assessing the effectiveness of vaccination programs. Governments invest in strengthening disease monitoring networks, enhancing diagnostic capabilities, and establishing reporting mechanisms to detect and respond to FMD cases promptly.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
The foot and mouth disease vaccines industry size was valued at USD 2.5 billion in 2023 and is anticipated to witness CAGR 7.7% CAGR from 2024 to 2032 driven by the rising prevalence of foot and mouth disease outbreaks, and substantial commercialization of livestock products.
The conventional vaccines type segment in the foot and mouth disease (FMD) vaccines market recorded 83.9% share in 2023 due to proven track record of success in various regions, particularly in endemic areas where the disease poses a constant threat.
North America FMD vaccines industry is predicted to witness 6.7% CAGR through 2032 led by the need for proactive approach towards safeguarding livestock and the agricultural sector
Biogénesis Bagó, Biovet Private Ltd, C.H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Indian Immunologicals Ltd., Merck & Co., Inc. and Inner Mongolia Biwei Antai Biotechnology Co., Ltd.